Leveraging biofluid markers as a real-time window to understand molecular drivers of sex differences in AD clinical trials.

Alzheimer's & Dementia

Kaitlin B. Casaletto. Leveraging biofluid markers as a real-time window to understand molecular drivers of sex differences in AD clinical trials. Alzheimer's & Dementia. 2024 Dec 1; 20(Suppl 6):e090948.

2024
https://researcherprofiles.org/profile/580373076

Kaitlin B. Casaletto